Previous comparisons of standard temporal lobectomy (STL) and selective amygdalohippocampectomy (SelAH) have been limited by inadequate long-term follow-up, variable definitions of favorable outcome, and inadequate consideration of psychiatric comorbidities.
The authors performed a retrospective analysis of seizure, cognitive, and psychiatric outcomes in a noncontemporaneous cohort of 69 patients with unilateral refractory temporal lobe epilepsy and MRI evidence of mesial temporal sclerosis after either an STL or an SelAH and examined seizure, cognitive, and psychiatric outcomes.
The mean duration of follow-up for STL was 9.7 years (range 1–18 years), and for trans–middle temporal gyrus SelAH (mtg-SelAH) it was 6.85 years (range 1–15 years). There was no significant difference in seizure outcome when “favorable” was defined as time to loss of Engel Class I or II status; better seizure outcome was seen in the STL group when “favorable” was defined as time to loss of Engel Class IA status (p = 0.034). Further analysis revealed a higher occurrence of seizures solely during attempted medication withdrawal in the mtg-SelAH group than in the STL group (p = 0.016). The authors found no significant difference in the effect of surgery type on any cognitive and most psychiatric variables. Standard temporal lobectomy was associated with significantly higher scores on assessment of postsurgical paranoia (p = 0.048).
Overall, few differences in seizure, cognitive, and psychiatric outcome were found between STL and mtg-SelAH on long-term follow-up. Longer exposure to medication side effects after mtg-SelAH may adversely affect quality of life but is unlikely to cause additional functional impairment. In patients with high levels of presurgical psychiatric disease, mtg-SelAH may be the preferred surgery type.
Abbreviations used in this paper:AED = antiepileptic drug; ATN = anterior temporal neocortex; EEG = electroencephalography; MMPI-2 = Minnesota Multiphasic Personality Inventory-2; mtg-SelAH = trans–middle temporal gyrus SelAH; MTS = mesial temporal sclerosis; SelAH = selective amygdalohippocampectomy; STL = standard temporal lobectomy; TLE = temporal lobe epilepsy.
Address correspondence to: Krzysztof A. Bujarski, M.D., Department of Neurology, Dartmouth-Hitchcock Medical Center, One Medical Center Drive, Lebanon, New Hampshire 03756. email: Krzysztof.A.Bujarski@Dartmouth.edu.
Please include this information when citing this paper: published online April 26, 2013; DOI: 10.3171/2013.3.JNS12714.
Cohen-GadolAAWilhelmiBGCollignonFWhiteJBBrittonJWCambierDM: Long-term outcome of epilepsy surgery among 399 patients with nonlesional seizure foci including mesial temporal lobe sclerosis. J Neurosurg104:513–5242006
HelmstaedterCElgerCEHufnagelAZentnerJSchrammJ: Different effects of left anterior temporal lobectomy, selective amygdalohippocampectomy, temporal cortical lesionectomy on verbal learning, memory, and recognition. J Epilepsy9:39–451996
HelmstaedterCRichterSRöskeSOltmannsFSchrammJLehmannTN: Differential effects of temporal pole resection with amygdalohippocampectomy versus selective amygdalohippocampectomy on material-specific memory in patients with mesial temporal lobe epilepsy. Epilepsia49:88–972008
MargerisonJHCorsellisJAN: Epilepsy and the temporal lobes. A clinical, electroencephalographic and neuropathological study of the brain in epilepsy, with particular reference to the temporal lobes. Brain89:499–5301966
PaglioliEPalminiAPortuguezMPaglioliEAzambujaNda CostaJC: Seizure and memory outcome following temporal lobe surgery: selective compared with nonselective approaches for hippocampal sclerosis. J Neurosurg104:70–782006
SchmidtDBaumgartnerCLöscherW: Seizure recurrence after planned discontinuation of antiepileptic drugs in seizure-free patients after epilepsy surgery: a review of current clinical experience. Epilepsia45:179–1862004